E2F4 iRASs were calculated for samples in bladder cancer [36], colon cancer [39], NSCLC [38], glioblastoma [37], AML [40], and Burkitt’s lymphoma [41] datasets and used in conjunction with the available survival data to generate Kaplan-Meier plots (Figure 7). Here, E2F4 is linked to malignant colon neoplasm.